Watts GS - Search Results

1

Epigenetic inactivation of the HOXA gene cluster in breast cancer.

Novak P, Jensen T, Oshiro MM, Wozniak RJ, Nouzova M, Watts GS, Klimecki WT, Kim C, Futscher BW. Novak P, et al. Among authors: watts gs. Cancer Res. 2006 Nov 15;66(22):10664-70. doi: 10.1158/0008-5472.CAN-06-2761. Epub 2006 Nov 6. Cancer Res. 2006. PMID: 17090521

2

Detecting differences in 5-methylcytosine using restriction enzyme isoschizomers: an endogenous control for complete digestion.

Watts GS, Futscher BW. Watts GS, et al. Nucleic Acids Res. 1995 Nov 25;23(22):4740-1. doi: 10.1093/nar/23.22.4740. Nucleic Acids Res. 1995. PMID: 8524671 Free PMC article.

3

Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene.

Watts GS, Pieper RO, Costello JF, Peng YM, Dalton WS, Futscher BW. Watts GS, et al. Mol Cell Biol. 1997 Sep;17(9):5612-9. doi: 10.1128/MCB.17.9.5612. Mol Cell Biol. 1997. PMID: 9271436 Free PMC article.

4

Laminin-5-mediated gene expression in human prostate carcinoma cells.

Calaluce R, Kunkel MW, Watts GS, Schmelz M, Hao J, Barrera J, Gleason-Guzman M, Isett R, Fitchmun M, Bowden GT, Cress AE, Futscher BW, Nagle RB. Calaluce R, et al. Among authors: watts gs. Mol Carcinog. 2001 Feb;30(2):119-29. doi: 10.1002/1098-2744(200102)30:2<119::aid-mc1020>3.0.co;2-n. Mol Carcinog. 2001. PMID: 11241759

5

cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways.

Watts GS, Futscher BW, Isett R, Gleason-Guzman M, Kunkel MW, Salmon SE. Watts GS, et al. J Pharmacol Exp Ther. 2001 Nov;299(2):434-41. J Pharmacol Exp Ther. 2001. PMID: 11602652

6

Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate.

Crowley-Weber CL, Payne CM, Gleason-Guzman M, Watts GS, Futscher B, Waltmire CN, Crowley C, Dvorakova K, Bernstein C, Craven M, Garewal H, Bernstein H. Crowley-Weber CL, et al. Among authors: watts gs. Carcinogenesis. 2002 Dec;23(12):2063-80. doi: 10.1093/carcin/23.12.2063. Carcinogenesis. 2002. PMID: 12507930

7

Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression.

Oshiro MM, Watts GS, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE, Futscher BW. Oshiro MM, et al. Among authors: watts gs. Oncogene. 2003 Jun 5;22(23):3624-34. doi: 10.1038/sj.onc.1206545. Oncogene. 2003. PMID: 12789271

8

The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells.

Watts GS, Oshiro MM, Junk DJ, Wozniak RJ, Watterson S, Domann FE, Futscher BW. Watts GS, et al. Neoplasia. 2004 May-Jun;6(3):187-94. doi: 10.1593/neo.3292. Neoplasia. 2004. PMID: 15153330 Free PMC article.

9

AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells.

Li H, Watts GS, Oshiro MM, Futscher BW, Domann FE. Li H, et al. Among authors: watts gs. Oncogene. 2006 Aug 31;25(39):5405-15. doi: 10.1038/sj.onc.1209534. Epub 2006 Apr 24. Oncogene. 2006. PMID: 16636674

10

Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161.

Ignatenko NA, Yerushalmi HF, Watts GS, Futscher BW, Stringer DE, Marton LJ, Gerner EW. Ignatenko NA, et al. Among authors: watts gs. Technol Cancer Res Treat. 2006 Dec;5(6):553-64. doi: 10.1177/153303460600500602. Technol Cancer Res Treat. 2006. PMID: 17121431 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters